Galmed Pharmaceuticals Ltd.
13F holders, Q1 2024 (March 31)13holders
$0.33avg. 13F price*
At the end of Q1 2024, 13 institutions reported holding Galmed Pharmaceuticals Ltd. in their 13F filings. The largest holders were CVI Holdings, LLC ($25K), Walleye Capital LLC ($14K) and Two Sigma Advisers, LP ($8K).
- Company
- Galmed Pharmaceuticals Ltd.
- CUSIP
- M47238122
- Latest filing quarter
- Q2 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $6K |
| Exits | 3 | $16K |
Ownership 13 holders
| CVI Holdings, LLC | 0.02% | Reduce -72.3% | 74,665 | $25K |
| Walleye Capital LLC | 0.00% | Reduce -63.6% | 42,012 | $14K |
| Two Sigma Advisers, LP | 0.00% | Reduce -49.9% | 22,267 | $8K |
| Two Sigma Securities, LLC | 0.00% | New | 16,306 | $6K |
| Morgan Stanley | 0.00% | Reduce -82.4% | 14,498 | $5K |
| UBS Group AG | 0.00% | New | 2,260 | $782 |
| Wells Fargo & Company | 0.00% | No change | 204 | $71 |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 167 | $58 |
| Osaic Holdings, Inc. | 0.00% | No change | 53 | $18 |
| Allworth Financial LP | 0.00% | No change | 17 | $6 |
| Elevation Wealth Partners, LLC | 0.00% | No change | 7 | $3 |
| Bank of America Corp. | 0.00% | No change | 1 | $0 |
| Tsfg, LLC | 0.00% | No change | 200 | $0 |
"% of holder's portfolio" is GALMED PHARMACEUTICALS LTD's weight in each manager's 13F, not the share of Galmed Pharmaceuticals Ltd. the manager owns.